a. kumar, c.p. cannon. arch med sci 2007;3:s115-s125
DESCRIPTION
Coronary heart disease (CHD) event rates in secondary prevention and acute coronary syndrome trials. A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125. Number of ruptured plaques in addition to ruptured lesion in acute coronary syndrome (80% of patients with ≥1 ruptured plaque). - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/1.jpg)
Coronary heart disease (CHD) event rates in secondary prevention and acute coronary syndrome trials
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 2: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/2.jpg)
Number of ruptured plaques in addition to ruptured lesion in acute coronary syndrome (80% of patients with ≥1 ruptured plaque)
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 3: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/3.jpg)
Integrated approach to managing patients with acute coronary syndrome
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 4: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/4.jpg)
Kaplan-Meier estimates of the incidence of primary endpoint of death from any cause or a major
cardiovascular event in PROVE IT-TIMI 22
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 5: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/5.jpg)
“Pleiotropic” effects of statinsin acute coronary syndrome
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 6: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/6.jpg)
Cumulative incidence of recurrent myocardial infarction or death from coronary causes according to the achieved levels of both low density lipoprotein (LDL) cholesterol
and C-reactive protein (CRP) in PROVE IT-TIMI 22
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 7: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/7.jpg)
Relationship between the number of uncontrolled risk factors present and the median C-reactive protein (CRP) level for
standard versus intensive statin therapy in PROVE IT-TIMI 22
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 8: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/8.jpg)
Individual trials and pooled analysis showing a highly significant 16% reduction in the risk of coronary death or myocardial
infarction (p<0.0001); CI - confidence interval, OR - odds ratio
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 9: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/9.jpg)
Benefit of intensive statin therapy versus moderate statin therapy in reducing the risk of hospitalization for
heart failure in a meta-analysis of 27,546 patients
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 10: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/10.jpg)
Level of low density lipoprotein cholesterol achieved at 4 months and the long-term risk of
death or major cardiovascular event
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 11: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/11.jpg)
Risk of major cardiovascular events according to quintile of achieved low density lipoprotein (LDL)
cholesterol in Treating to New Targets study
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125
![Page 12: A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125](https://reader035.vdocuments.mx/reader035/viewer/2022062517/5681302c550346895d95c03b/html5/thumbnails/12.jpg)
Recent coronary intravascular ultrasound trials (relationship between mean low density lipoprotein cholesterol level and
progression rate of coronary atherosclerosis)
A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125